By vgreene, 12 January, 2021 Pts who previously had Bell s palsy Despite the fact that cases of Bell s palsy have been reported in participants of mRNA COVID 19 vaccine trials FDA doesn t consider these to be above the rate expected in the general population Nor has the agency conclu
By vgreene, 12 January, 2021 Pts w hx of Guillain Barre syndrome GBS To date no cases of GBS have been reported following vaccination among clinical trial participants
By vgreene, 12 January, 2021 Pts w HIV or other types of immunocompromise Such pts should be made aware of the limited safety date for this population the potential for reduced immune responses to the vaccine the importance of continuing to follow all current guidance to protect them
By vgreene, 12 January, 2021 CDC further clarifies that individuals w the following specific medical conditions may receive an mRNA vaccine 1
By vgreene, 12 January, 2021 Phase 2 3 clinical trials demonstrated similar safety and efficacy profiles in persons w underlying medical conditions incl those that place them at increased risk for severe COVID 19 compared to persons w o comorbidities 1
By vgreene, 12 January, 2021 Yes CDC says that pts w underlying medical conditions can safely receive the COVID 19 vaccine as long as there are no contraindications to vaccination such as a severe allergic reaction to any of its ingredients 1
By vgreene, 12 January, 2021 Some pts may ask about a false claim that s been circulating that says that mRNA vaccines can somehow attack a protein in the placenta syncytin trigger miscarriages Although these vaccines work by causing our immune systems to make antibodies to a spike p
By vgreene, 12 January, 2021 Refer to the ACOG practice guidelines to help understand vaccine options for pregnant lactating individuals 3
